InsidersTradesSigma
Follow the 엑세스바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엑세스바이오 has logged 9 insider filings. The latest transaction was reported on 29 January 2026 (Purchase). Among the most active insiders: 팜젠사이언스. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
Access Bio 是一家在XKRX市场上市的健康和制药公司。该公司专注于医疗诊断和健康技术开发。